Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancer Brain-penetrant PRMT5...

LOUISVILLE, Ky. — Greenworks Commercial showcased the OPTIMUS commercial ecosystem at Equip Exposition 2026 (formerly GIE+EXPO), held October 20–23 at the Kentucky Exposition Center. The ecosystem...

Guangzhou, China, Oct. 24, 2026 (GLOBE NEWSWIRE) -- Tec-Do today hosted Technology Growth Conference 2026 (TGC 2026) in Guangzhou under the theme “AI is Profitable.” Featuring AI pioneer Dr. Kevin...

SAN DIEGO, CA / ACCESS Newswire<https://www.accessnewswire.com/> / October 23, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI), the world leader in Uncrewed Aircraft Systems (UAS), today...

LONDON, UK / ACCESS Newswire<https://www.accessnewswire.com/> / October 23, 2026 / A large-scale survey published in Frontiers in Animal...

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 months TEVIMBRA-containing arm was...

NEW YORK--BUSINESS WIRE-- Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with...

SHANGHAI, CHINA / ACCESS Newswire<https://www.accessnewswire.com/> / October 23, 2026 / Leggett Dynamics<https://pr.report/smg4> today announced that its Mid-Class Massage System...

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics MADRID--BUSINESS WIRE-- Brenus...

* Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2 ADC, were Highlighted in a Late-Breaking Presentation at ESMO...